Menu

Press Releases and Bulletins

For more information on these press releases, contact: 

J. Benjamin Younger Office of Public Affairs
409 12th Street SW, Suite 602
Washington, DC 20024-2188
Tel: (202) 863-2494/Fax: (202) 484-4039 

Egg Donors Report Good Long-Term Physical Health Status and Satisfaction with their Experience

Philadelphia, PA- Researchers shared results today, at the 75th Annual Scientific Congress of the American Society for Reproductive Medicine, that most egg donors surveyed  reported positive feelings about their donation experience and continuing good health years after their donation.  Dr. Jennifer Blackmore and her colleagues analyzed responses to an anonymous survey completed by 36 egg donors who donated between 2008 and 2019 at New York University’s Langone Fertility Center. 

Men, Seriously. What Are You Thinking?

Philadelphia, PA- A preliminary analysis of results from an online survey show that men in the United States know somewhat less about fertility and infertility treatment than women do and are particularly optimistic- or confused- when it comes to what they think they know about female fertility and age.

Revised Guidelines Expanding Single Embryo Transfer Guidelines Result in Fewer Multiple Births at the Clinic Level and the National Level, Without a Decline in Live Birth Rates

Philadelphia, PA- Today, at the 75th Annual Scientific Congress and Expo of the American Society for Reproductive Medicine, researchers from the National Institute of Child Health and Human Development and Walter Reed National Military Medical Center presented results from a retrospective cohort study in which they compared Assisted Reproductive Technology outcomes in women under 38 years of age from the two years before and the two years after the 2017 revision of the ASRM/SART embryo transfer recommendations. The data showed a significant reduction in the number of embryos transferred and in twin pregnancy rates, but no reduction in over all live birth rates after the new recommendations were published and implemented. 

The Higher the Motile Sperm Count, the Greater the Number of Historical Kinfolk; Sperm Quality Measure May Be Heritable

Philadelphia, PA- Utah researchers presented a study today at ASRM’s 75th Scientific Congress and Expo showing that there is a relationship between a man’s total motile sperm count (TMC) as a marker of fertility, and the number of offspring his ancestors had through several generations. The better an individual’s TMC, the more children his ancestors had.

Racial Disparities in Fertility Care Persist

Philadelphia, PA – Research presented today at the 75th Scientific Congress of the American Society for Reproductive Medicine showed that while there had been a slight uptick in the use of Assisted Reproductive Technologies (ART) among African American women over the last decade, significant disparities remain.

Jury May Still Be out on Caffeine Use During Pregnancy

Philadelphia, PA – The ongoing debate about the safety of caffeine use during pregnancy got another data point today at the 75th Scientific Congress of the American Society for Reproductive Medicine. A team at the National Institutes of Health presented a study showing that the use of any level of caffeine, particularly during the first eight weeks of pregnancy, may increase the risk of pregnancy loss.

Preimplantation Genetic Testing for Chromosomal Defects Improves IVF Outcomes in Patients with Recurrent Pregnancy Loss

Philadelphia, PA- In the largest study to date examining the usefulness of preimplantation genetic testing for aneuploidy (PGT-A), for patients with recurrent pregnancy loss (RPL), Rutgers researchers report that PGT-A is associated with significant improvements in live birth, clinical pregnancy, and spontaneous abortion rates, especially in women over the age of 35.

ICSI Smoothie? Cocktail of Beetroot, Watermelon and Ginger Juice Show Promise in Helping Infertility Treatments

Philadelphia, PA – A study of nearly 300 infertility patients undergoing Intracytoplasmic Sperm Injection (ICSI) were enrolled in a clinical study to evaluate the effectiveness of certain nutritional supplements. The investigators found that the patients receiving the supplements had increased embryo implantation rates, higher clinical pregnancy rates and lower miscarriage rates than those in the control group.

Medical Society to Move Headquarters Out of Alabama

Washington, DC – The American Society for Reproductive Medicine, a major medical association celebrating its 75th anniversary this year, announced today it was moving its main headquarters from Birmingham, AL to Washington DC. The move comes in reaction to new laws in Alabama restricting access to reproductive medical services.

ASRM 75th Anniversary Gala SOLD OUT

The ASRM 75th Anniversary Gala to be held in Philadelphia on October 13th is completely sold out.

We look forward to this very special event. If you were unable to get a ticket for this year’s gala, stay tuned for information on a similar event at the ASRM 2020 Scientific Congress & Expo in Portland.

ASRM Announces Research Awards

Washington DC – The American Society for Reproductive Medicine today announced its 2019 ASRM Research Grants. The grants provide funds in amounts of $10,000 to $50,000 to foster the development of innovative research, to facilitate the research endeavors of new investigators, and to provide bridge funding for projects that advance the Society’s mission. Proposals from junior faculty, particularly those in their first three years of faculty appointment, received priority in the competitive review by the ASRM Research Committee. 

 

New Hampshire Expands Fertility Coverage to Employer-Sponsored Health Plans

On August 1st, Republican Governor Chris Sununu of New Hampshire signed SB 279 into law. This bill, passed by the legislature in late June, will expand insurance coverage for fertility care by requiring employer-sponsored plans to cover the care as well as the storage of sperm, eggs and embryos for the length of the policy. Group plans will also be required to cover fertility preservation for patients who must undergoe medically necessary treatment that may cause iatrogenic infertility. The new law will take effect on January 1, 2020.

House Passes National Defense Authorization Act with Language Addressing Infertility in Servicewomen; Rep. Scott Introduces Fibroid Awareness Resolution

On July 12th, the House passed the National Defense Authorization Act (NDAA) for 2020 by a vote of 220-197. The House version of the NDAA includes language calling for a Study on Infertility Among Members of the Armed Forces no later than 180 days after enactment. The findings will then be reported back to the members of the House Committee on Armed Services. The study will assess the number of members of the Armed Forces serving as of the date of the study who are diagnosed with common causes of infertility, such as: 

ASRM One of Ten National Health Organizations Urging Supreme Court to Find Louisiana Law Unconstitutional

Today, ASRM joined with nine other healthcare organization, led by ACOG, to file an amicus brief with the US Supreme Court in the case June Medical Services LLC v. Rebekah Gee.

In September 2018, the Fifth Circuit Court of Appeals overruled a challenge to a Louisiana law requiring that physicians providing abortion care have admitting privileges at a hospital within 30 miles of their clinics. The Louisiana law they upheld is virtually identical to the Texas law found unconstitutional by the Supreme Court in Whole Women’s Health vs. Texas in 2016.

Access to Infertility Treatment and Care Act Introduced

Washington, DC-- The Access to Infertility Treatment and Care Act (HR 2803 and S 1461) just introduced in Congress will require all health plans offered on the group and individual markets to provide coverage for the treatment of infertility. The Federal Employees Health Benefits Program, TRICARE, the VA and Medicaid are also included under the Act. In addition, the Act will require coverage for fertility preservation services for individuals who undergo a medically necessary procedure that may cause infertility, such as chemotherapy.

Advocacy Day 2019: ASRM Went to Capitol Hill to Garner Support for New Legislation to Ensure All Americans Have Coverage for Fertility Care

This year’s turnout was the largest to date, with 233 patients and professionals- members of ASRM and RESOLVE from 29 states and the District of Columbia-  in Washington, DC yesterday to meet with their Senators and Representatives to let them know how they can help Americans build their families via support for legislation important to the infertility community.  Before heading out to the Hill, advocates heard first hand from Rep. Debbie Wasserman Schultz, a long-time champion of legislation to help the infertility community, about her personal infertility and cancer journeys, and her call to action.

Oral Contraceptives May Limit Bone Loss in Young Anorexic Patients

French researchers have identified a promising protective effect of oral contraceptives on the bone health of young women with anorexia nervosa.  Along with the gynecological disorders resulting from anorexia, patients experience bone loss with intense demineralization early in the course of the disease. This study shows for the first time that anorexia patients using oral contraceptives (OCs) have a higher areal bone mineral density than those who do not use OCs  and suggests that, while regularly taking an oral contraceptive will not confer complete protection, it may help to limit bone loss in young women suffering from anorexia nervosa.

ASRM and RESOLVE Announce New Partnership Agreement

ASRM is proud to announce that we have entered into an agreement with RESOLVE: the National Infertility Association to form a new partnership focused on access to care and patient education efforts. ASRM and RESOLVE have a long and successful history of working together to improve conditions for patients, and this agreement brings a new, more formal status to that relationship. The joint efforts will focus on three areas: supporting RESOLVE’s Coverage at Work initiative, working together on policy advocacy efforts, and improving ASRM’s Patient Education offerings.

 

New York Becomes Tenth State to Require Coverage of IVF and Sixth State to Require Coverage for Fertility Preservation for Certain Patients

New York lawmakers passed a budget measure late yesterday which updates the state’s existing infertility statute to include a requirement for health plans operating in the large group market (employers with 100 or more full-time staff) to provide coverage for three cycles of in-vitro fertilization. The budget measure also includes a provision requiring that patients at risk for iatrogenic infertility be covered for fertility preservation services. 

DEADLINE April 26, 2019 - The ASRM Research Institute Solicits its First Round of Major Grant Applications

The newly established ASRM Research Institute invites applications from investigators to develop research projects addressing fundamental questions of major clinical significance to reproductive medicine. Preference for funding will be given to projects that attempt to answer timely, basic and clinically relevant questions of potential high impact to the practice of reproductive medicine and which are currently not fundable (either because of applicable existing federal law or because of relatively lower prioritization) by federal funding agencies. Applicants are advised to review the recently published ASRM Research Blueprint identifying the list of research priorities for the Society.

ASRM Goes to Geneva for the World Health Organization’s Global Summit on Safety and Access to Fertility Care

This week, members of ASRM’s leadership team are meeting with other leaders in reproductive health from around the world in Geneva, Switzerland. The WHO is holding its Global Summit on Safety and Access to Fertility Care to develop strategies for improving access to safe, ethical, and cost-effective fertility care, particularly in developing countries. This conference follows up on an ASRM-sponsored meeting in 2015.

ASRM Statement on Reports of Human Reproductive Gene-Editing in China

Statement attributable to ASRM President, Peter Schlegel, MD.

 

“We have reviewed the report of He Jiankui of Shanghai, China, regarding the initiation of a twin pregnancy after premature human application of the unfolding scientific technique of CRISPER/Cas to modify genes in human embryos as part of an in vitro fertilization (IVF) procedure.  Although gene editing may have an important place in human medicine in the future, it should only be used clinically after careful study done with vigorous oversight. 

ReproductiveFacts.org
is a patient education website of ASRM.
 

Zika